Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-09-29
1988-07-19
Fan, Jane T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546322, C07D21389, A61K 31465
Patent
active
047585811
ABSTRACT:
N-oxides of pyridyl carboxylic acid esters of the following formula are described: ##STR1## wherein R is ##STR2## wherein X is a hydrogen atom, straight or branched C.sub.1 -C.sub.5 -alkyl, C.sub.5 -C.sub.12 -cycloalkyl, 1-adamantyl, or cyclohexylacetyl, and
wherein Y is a hydrogen atom, straight or branched C.sub.1 -C.sub.5 -alkyl, 2-ethylbenzofuranoyl-3, C.sub.5 -C.sub.12 -cycloalkyl, or 2-[(4-chlorophenoxy)-2-methylpropanoyloxy]ethyl;
a process for the manufacture thereof, pharmaceutical compositions containing these compounds, and method of using the same. These compounds are suited for use in the treatment of hyperlipidemas.
REFERENCES:
patent: 3622587 (1971-11-01), Carlson et al.
patent: 4321268 (1982-03-01), Scherm et al.
Bickel Pharmacological Reviews 1969, vol. 21, No. 4, pp. 325, 333, 340.
G. J. Miller, "Plasma-High-Density-Lipoprotein Concentration and Devlopment or Ischaemic Heart-Disease", The Lancet, Jan. 4, 1975.
G. V. H. Bradby, et al., "Serum High-Density Lipoproteins in Peripheral Vascular Disease", The Lancet, Dec. 16, 1978.
James J. Maciejko, Ph.D., et al.; "Apolipoprotein A-I as a Marker of Angiographically Assessed Coronary-Artery Disease", The New England Journal of Medicine, vol. 309, Aug. 18, 1983, No. 7.
Norman E. Miller, "Induction of Low Density Lipoprotein Receptor Synthesis by High Density Lipoprotein in Cultures of Human Skin Fibroblasts", Biochemica et Biophysica Acta, 529 (1978) 131-137.
Michael S. Brown, et al., "The Cholesteryl Ester Cycle in Macrophage Foam Cells, The Journal of Biological Chemistry, vol. 255, No. 19, Oct. 10, pp. 9344-9352, 1980.
John F. Oram, et al., "The Effects of Subfractions of High Density Lipoprotein on Cholesterol Efflux from Cultured Fibroblasts", The Journal of Biological Chemistry, vol. 256, No. 16, Aug. 25, 1981, pp. 8348-8356.
George H. Rothblat, et al., "Mechanism of Cholesterol Efflux from Cells", The Journal of Biological Chemistry, vol. 257, No. 9, May 10, 1982, pp. 4775-4782.
Rebecca J. Daniels, et al., "Studies on the Rate of Efflux of Cholesterol from Cultured Human Skin Fibroblasts", The Journal of Biological Chemistry, vol. 256, No. 10, May 25, 1981, pp. 4978-4983.
O. Stein, et al., "Cholesterol Content & Sterol Synthesis in Human Skin Fibroblasts & Rat Aortic Smooth Muscle Cells Exposed to Lipoprotein-Depleted Serum & High Density Apolipoprotein/Phospholipid Mixtures", Biochimica et Biophysica Acta, 431 (1976) 347-358.
D. Reichl, et al., "Evidence for the Presence of Tissue-Free Cholesterol in Low Density & High Density Lipoproteins of Human Peripheral Lymph", Atherosclerosis, 37 (1980) 489-495.
L. K. Miller, et al., "Side-Chain Oxidation of Lipoprotein-Bound [24,25-.sup.3 H] Cholesterol in the Rat: Comparison of HDL and LDL and Implications for Bile Acid Synthesis", Journal of Lipid Research, vol. 23, 1982, pp. 335-343.
Von P. Roschlau, et al., "Enzymatische Bestimmung Des Gesamt-Cholesterol Im Serum", Z. Klin. Chem. Klun. Biochem., 12 Jg. 1974, S. 403-407.
Thomas P. Bersot, et al., "Lipoprotein Receptors in Lipid Transport & Artherogenesis", Artherosclerosis: Mechanisms and Approaches to Therapy, Raven Press, New York, 1983, pp. 143-152.
Tatu A. Miettinen, et al., "Effect of Long-Term Antihypertensive & Hypolipidemic Treatment on High Density Lipoprotein Cholesterol & Apolipoproteins A-I and A-II", Atherosclerosis, 36 (1980) 249-259.
Fiedler, "Die Pharmazie", vol. 20, No. 7, pp. 401-404 (Jul. 1965) and certified translation into English.
Fiedler, Chem. Abs. 63, 11486e (1965).
Fiedler, Chem. Abs. Index, 3790F and C18H19N02S (1965).
Prino et al., "Antithrombotic Activity of Polydesoxynucleotidic-Like Substance (Fraction P), Advances in Coagulation, Fibrinolysis, Platelet Aggregation and Atherosclerosis 1976, pp. 282-289.
Subissi et al., "Acute Effects on Plasma Lipids in the Rat of a New Long-Acting Nicotinic Acid Derivative: LG 13979", J. Pharm. Pharmacol. 1983, 35:571-575.
Hummel Klaus
Peteri Dezsoe
Schatton Wolfgang
Scherm Arthur
Fan Jane T.
Hueschen Gordon W.
Merz & Co. GmbH & Co.
LandOfFree
Pyridyl N-oxides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyridyl N-oxides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridyl N-oxides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-597564